VNDA
Vanda Pharmaceuticals Inc
4.60$
-1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 83.6% | 66.8% | 67.3% | 67.4% | 67.0% | 66.9% | 64.5% | 63.2% | 61.1% | 71.0% | 67.6% | 64.1% | |
| 28.6% | 20.9% | 19.2% | 15.8% | 15.6% | 15.6% | 17.7% | 13.0% | 11.6% | 17.4% | 12.5% | 13.5% | |
| 76.3% | 59.9% | 60.4% | 59.5% | 58.3% | 57.1% | 53.9% | 52.1% | 48.9% | 54.0% | 46.7% | 41.2% | |
| 4.6% | 5.3% | 5.6% | 6.4% | 6.6% | 7.2% | 7.1% | 7.2% | 8.4% | 11.2% | 13.1% | 14.5% | |
| 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | |
| 2.7% | 18.7% | 18.3% | 18.1% | 18.0% | 17.4% | 17.8% | 17.7% | 18.1% | 23.9% | 26.6% | 27.4% | |
| 15.4% | 16.0% | 16.7% | 16.7% | 16.1% | 17.9% | 19.1% | 22.2% | 22.5% | 33.1% | 35.2% | 46.6% | |
| 13.2% | 13.5% | 14.3% | 14.4% | 13.8% | 15.2% | 16.4% | 19.4% | 19.6% | 29.7% | 31.3% | 39.8% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.7% | 0.7% | 0.7% | 0.8% | 1.1% | 1.4% | 1.1% | |
| 0.5% | 1.1% | 1.0% | 0.6% | 0.9% | 0.5% | 0.9% | 0.3% | 0.5% | 1.0% | 1.0% | 2.1% | |
| 84.6% | 84.0% | 83.3% | 83.3% | 83.9% | 82.1% | 80.9% | 77.8% | 77.5% | 66.9% | 64.8% | 53.4% | |
| -23.8% | -24.0% | -24.4% | -25.2% | -26.3% | -26.6% | -32.2% | -37.0% | -42.2% | -80.7% | -102.3% | -122.6% | |
| 9.0% | 8.9% | 8.8% | 8.9% | 9.0% | 8.9% | 9.3% | 9.4% | 9.8% | 12.1% | 13.7% | 14.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.